Ipamorelin

IPAMORELIN 10MG

Manufacturer: GetVital
Package: 10 mg/vial
Common Names: Ipamorelin, Ipamorelin Acetate, NNC 26-0161, Growth Hormone Secretagogue Peptide

Info: Ipamorelin is a synthetic pentapeptide belonging to the class of growth hormone secretagogues. It has been investigated for its selective interaction with growth hormone secretagogue receptors and its ability to influence the release of endogenous growth hormone. Research involving Ipamorelin focuses on growth hormone signaling, endocrine regulation, metabolic pathways, and physiological processes associated with growth hormone activity.

Effects

Growth Hormone Research: Ipamorelin has been studied for its ability to stimulate endogenous growth hormone secretion through activation of growth hormone secretagogue receptors. Research has examined its effects on growth hormone release without directly supplying exogenous growth hormone.

Dosage Range and Duration of Use

Ipamorelin 10 mg (10 mg/vial): Each vial contains 10 mg of Ipamorelin in lyophilized form and requires appropriate preparation using sterile procedures before administration.

In research and clinical protocols, subcutaneous administration typically ranges from 200 mcg to 300 mcg per dose, administered one to three times daily. Due to its short active half-life of approximately 2 hours, researchers often schedule administrations before bed or prior to exercise to maximize growth hormone release. Standard experimental courses generally last between 8 to 12 weeks, with dosing frequency and total duration determined according to specific study designs and professional guidance.

Side Effects

The complete safety profile of Ipamorelin has not been established for all routes of administration and research applications. Potential reactions may vary according to dosage, exposure, administration method, individual characteristics, and concurrent substances. Reported or theoretically possible reactions may include injection-site irritation, redness, swelling, headache, dizziness, nausea, fatigue, and changes associated with fluid balance or hormonal activity.

Post-Cycle Therapy

Ipamorelin is a peptide and is not an anabolic steroid, androgenic compound, or testosterone-suppressing anabolic agent. It therefore does not require conventional post-cycle therapy (PCT) protocols associated with anabolic steroid use. As a research peptide that influences growth hormone signaling, its use should nevertheless remain within an appropriate medical or scientific framework.

Storage:

Store lyophilized Ipamorelin according to the manufacturer's storage specifications and protect the vial from excessive heat, moisture, and direct exposure to light. After reconstitution, storage requirements and stability may depend on the diluent, concentration, preparation method, and manufacturer's instructions.